Published in JACC Cardiovasc Imaging on January 01, 2015
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med (2000) 3.90
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med (2008) 3.33
Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med (2014) 2.90
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA (2014) 2.39
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA (2014) 1.72
Calcific aortic valve stenosis: methods, models, and mechanisms. Circ Res (2011) 1.70
Pioglitazone attenuates valvular calcification induced by hypercholesterolemia. Arterioscler Thromb Vasc Biol (2013) 0.99
New therapeutic targets for calcific aortic valve stenosis: the lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidized phospholipid axis. J Am Coll Cardiol (2013) 0.88
Aortic valve calcium content does not predict aortic valve area. J Heart Valve Dis (2006) 0.86
Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study. JACC Cardiovasc Imaging (2014) 0.85